(VERO) – Globe Newswire
-
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
-
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
-
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
-
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
-
Venus Concept Launches “NEXThetics” Program
-
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
-
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
-
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
-
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
-
Venus Concept Inc. Announces Review of Strategic Alternatives
-
Venus Concept Inc. Announces Issuance of $2.0M of Convertible Notes
-
Venus Concept Launches Venus Prime
-
Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
-
Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
-
Venus Concept Launches Venus Versa Pro, its new multi-application platform for face and body treatments
-
Venus Concept Launches New “Venus Aesthetic Intelligence” Branding and Updated “Venus.ai” Website to Reflect New Vision for the Company
-
Venus Concept Inc. Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
-
Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023
-
Venus Concept Inc. Announces Debt Restructuring, Preliminary Third Quarter 2023 Revenue Results and Updates Fiscal Year 2023 Revenue Guidance
-
Venus Concept Receives 510(k) Clearance for the Venus Versa Pro System, Its New Multi-Application Platform
-
Venus Concept Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
-
Venus Concept Announces Second Quarter of Fiscal Year 2023 Financial Results
-
Venus Concept Announces Second Quarter of Fiscal Year 2023 Financial Results
-
Venus Concept Announces Establishment of Medical Advisory Board For AI.ME™ -Its Next Generation Robotic Platform
-
Venus Concept to Release Second Quarter of Fiscal Year 2023 Financial Results on August 14, 2023
-
Venus Concept Announces First Quarter of Fiscal Year 2023 Financial Results
-
Venus Concept Inc. Announces Multi-Tranche Private Placement of Senior Convertible Preferred Stock for up to $9 Million with EW Healthcare Partners
-
Venus Concept Announces 1-for-15 Reverse Stock Split
-
Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023
-
Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance
-
Venus Concept Announces the Launch of its latest generation of ARTAS iX, the World’s Most Advanced Robotic Hair Restoration System
-
Venus Concept to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 27, 2023
-
Venus Concept Announces Strategic Business Realignment to Accelerate Its Path to Long-Term, Sustainable, Profitability and Reports Preliminary Revenue Results for Fourth Quarter and Fiscal Year 2022
-
Venus Concept Receives 510(k) Clearance for Use of its AI.ME™ Next Generation Robotic Technology for Fractional Skin Resurfacing
-
Venus Concept Announces Completion of $6.72 Million Private Placement Financing
-
Venus Concept Announces Third Quarter of Fiscal Year 2022 Financial Results
-
Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Venus Concept Appoints Dr. Hemanth Varghese as President & Chief Business Officer
-
Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results
-
Venus Concept Announces Appointment of Rajiv De Silva as Chief Executive Officer and Director; Updates Fiscal Year 2022 Revenue Guidance
-
Venus Concept Announces Second Quarter of Fiscal Year 2022 Financial Results; Updates Fiscal Year 2022 Revenue Guidance
-
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022
-
Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance
-
Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX
-
Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles
-
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
Back to VERO Stock Lookup
